Recruitment is underway for a pivotal proof-of-concept human trial of The University of Queensland’s second-generation molecular clamp vaccine.
Seventy healthy volunteers are needed for the study at Nucleus Network in Brisbane, to demonstrate the potential benefits of the re-engineered vaccine platform.
